As pharmaceutical development grows more intricate, Chemistry, Manufacturing, and Controls (CMC) stands at the forefront of innovation, compliance, and efficiency. While traditional CMC principles remain vital, 2026
In the high-stakes world of regulatory affairs, the Chemistry, Manufacturing, and Controls (CMC) section of a New Drug Application (NDA) or Marketing Authorization Application (MAA)
Medical Digital Twins — When the Soul Meets the Body in Medicine For centuries, doctors have treated the human body by looking outward—at symptoms, scans,
Bridging the Gap: AI Tools That Reduce Sponsor–Site Friction The success of a clinical trial often hinges on sponsors and sites coordination. Three areas in
How Agentic AI is Shaping the Future of Clinical Trials The life sciences industry is at a turning point — and the most significant shift
In 2025, as pharmaceutical sponsors push for faster, more efficient, and patient-centric drug development, CROs must move beyond traditional service delivery models. Embracing digital-first strategies
The transformation of clinical trials into efficient, compliant, and patient-focused ecosystems is no longer a future ambition — it’s happening now, decisively driven by automation.
How AI in Patient Recruitment Cuts Trial Timeline? According to a Tufts CSDD report nearly 80% of clinical trials fail to meet enrollment timelines. Can
Hyper Automation in Life Sciences and Clinical Research: Driving Efficiency and Inclusivity In the ever-evolving sectors of life sciences and clinical research, organizations are consistently